NATURAL CAPSULES
|
NATURAL CAPSULES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 19.82 | 19.56 | 10.99 | 1.38 | 3.08 |
| CEPS(Rs) | 27.66 | 27.03 | 14.76 | 6.55 | 6.73 |
| DPS(Rs) | - | - | 1.00 | 0.60 | 1.00 |
| Book NAV/Share(Rs) | 132.85 | 118.34 | 99.63 | 89.24 | 89.04 |
| Tax Rate(%) | 26.19 | 28.23 | 24.50 | 37.44 | 7.16 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.91 | 17.98 | 13.96 | 8.85 | 8.45 |
| EBIT Margin(%) | 16.66 | 15.89 | 12.20 | 3.70 | 4.35 |
| Pre Tax Margin(%) | 14.50 | 14.35 | 11.51 | 2.23 | 3.46 |
| PAT Margin (%) | 10.70 | 10.30 | 8.69 | 1.39 | 3.21 |
| Cash Profit Margin (%) | 14.88 | 14.03 | 14.11 | 8.09 | 8.56 |
| Performance Ratios | |||||
| ROA(%) | 8.14 | 10.65 | 8.05 | 1.16 | 2.66 |
| ROE(%) | 17.89 | 19.18 | 11.74 | 1.54 | 3.50 |
| ROCE(%) | 16.18 | 20.75 | 14.52 | 3.71 | 4.51 |
| Asset Turnover(x) | 0.76 | 1.03 | 0.93 | 0.83 | 0.83 |
| Sales/Fixed Asset(x) | 1.32 | 1.36 | 1.02 | 0.91 | 0.94 |
| Working Capital/Sales(x) | 4.99 | 4.38 | 4.88 | 3.12 | 2.72 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.76 | 0.74 | 0.98 | 1.10 | 1.07 |
| Receivable days | 83.04 | 71.61 | 130.95 | 185.47 | 193.73 |
| Inventory Days | 14.22 | 15.12 | 27.29 | 28.45 | 36.68 |
| Payable days | 100.67 | 97.82 | 112.34 | 99.07 | 139.86 |
| Valuation Parameters | |||||
| PER(x) | 19.83 | 23.63 | 8.03 | 19.58 | 17.30 |
| PCE(x) | 14.21 | 17.10 | 5.98 | 4.11 | 7.92 |
| Price/Book(x) | 2.96 | 3.91 | 1.08 | 0.37 | 0.73 |
| Yield(%) | - | - | 0.93 | 1.83 | 1.54 |
| EV/Net Sales(x) | 2.63 | 2.75 | 0.94 | 0.42 | 0.76 |
| EV/Core EBITDA(x) | 12.64 | 14.01 | 6.33 | 4.03 | 7.34 |
| EV/EBIT(x) | 15.81 | 17.30 | 7.73 | 11.33 | 17.48 |
| EV/CE(x) | 1.57 | 2.26 | 0.77 | 0.35 | 0.62 |
| M Cap / Sales | 2.11 | 2.40 | 0.84 | 0.33 | 0.68 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 27.62 | 69.86 | 29.18 | 2.97 | 9.18 |
| Core EBITDA Growth(%) | 35.54 | 124.10 | 84.85 | 3.39 | -2.52 |
| EBIT Growth(%) | 33.78 | 121.35 | 325.70 | -12.31 | 28.83 |
| PAT Growth(%) | 32.57 | 101.29 | 706.04 | -55.35 | 72.84 |
| EPS Growth(%) | 1.31 | 78.04 | 698.55 | -55.35 | 72.84 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.78 | 0.63 | 0.16 | 0.11 | 0.10 |
| Current Ratio(x) | 1.52 | 1.69 | 1.49 | 2.10 | 2.34 |
| Quick Ratio(x) | 1.38 | 1.59 | 1.29 | 1.80 | 2.24 |
| Interest Cover(x) | 7.70 | 10.31 | 17.84 | 2.51 | 4.90 |
| Total Debt/Mcap(x) | 0.26 | 0.12 | 0.14 | 0.31 | 0.13 |
Compare Financial Ratios of peers of NATURAL CAPSULES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATURAL CAPSULES | ₹330.2 Cr | 10.3% | 10.6% | -27.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
| CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics | |
NATURAL CAPSULES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATURAL CAPSULES | 10.3% |
10.6% |
-27.9% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
